News Beep
  • News Beep
  • Top stories
  • United States
  • United Kingdom
  • Canada
  • Australia
  • New Zealand
  • Ireland
News Beep
News Beep
  • News Beep
  • Top stories
  • United States
  • United Kingdom
  • Canada
  • Australia
  • New Zealand
  • Ireland

Browsing Tag

novartis

7 posts
HHeadlines
Novartis to acquire Tourmaline Bio, complementing cardiovascular pipeline with pacibekitug for the treatment of atherosclerotic cardiovascular disease (ASCVD)
Read More

Novartis opens new radioligand therapy manufacturing facility in California as part of $23B US expansion plan

  • November 10, 2025
Carlsbad location is company’s third US-based radioligand therapy (RLT) manufacturing site New site expands manufacturing footprint to meet…
HHeadlines
Novartis to acquire Tourmaline Bio, complementing cardiovascular pipeline with pacibekitug for the treatment of atherosclerotic cardiovascular disease (ASCVD)
Read More

Novartis announces expiration of Tourmaline Bio tender offer 

  • October 28, 2025
Basel, October 28 2025 – Novartis today announced that its previously announced tender offer (the “offer”) by Torino Merger…
HHeadlines
Novartis to acquire Tourmaline Bio, complementing cardiovascular pipeline with pacibekitug for the treatment of atherosclerotic cardiovascular disease (ASCVD)
Read More

PSMAddition data show Novartis Pluvicto™ delays progression to end-stage prostate cancer

  • October 19, 2025
PluvictoTM plus standard of care (ARPI + ADT) significantly reduced risk of progression or death by 28% (HR…
HHeadlines
Trump announces new tariffs on pharmaceuticals from October – The Irish Times
Read More

Trump announces new tariffs on pharmaceuticals from October – The Irish Times

  • September 26, 2025
The Government has said a deal capping future US tariffs on imports of pharmaceuticals from Europe still stands,…
HHeadlines
Novartis to acquire Tourmaline Bio, complementing cardiovascular pipeline with pacibekitug for the treatment of atherosclerotic cardiovascular disease (ASCVD)
Read More

Novartis to acquire Tourmaline Bio, complementing cardiovascular pipeline with pacibekitug for the treatment of atherosclerotic cardiovascular disease (ASCVD)

  • September 10, 2025
  Tourmaline Bio is a clinical-stage biopharmaceutical company developing pacibekitug, an anti-IL-6 mAb, as a treatment option for…
HHeadlines
Novartis announces both ianalumab Phase III clinical trials met primary endpoint in patients with Sjögren’s disease  
Read More

New Novartis ESC data highlights strength of cardiovascular portfolio

  • August 18, 2025
PRESS RELEASE Two VictORION studies will highlight Leqvio’s impact on patient quality of life, and as a cholesterol…
HHeadlines
Novartis announces both ianalumab Phase III clinical trials met primary endpoint in patients with Sjögren’s disease  
Read More

Novartis announces both ianalumab Phase III clinical trials met primary endpoint in patients with Sjögren’s disease  

  • August 11, 2025
Ad hoc announcement pursuant to Art. 53 LR NEPTUNUS-1 and NEPTUNUS-2 are the first ever global phase III…
News Beep
www.newsbeep.com